Kesselheim AS - Search Results

Year	Number of Results
2001	2
2002	1
2005	3
2006	7
2007	5
2008	9
2009	9
2010	15
2011	23
2012	19
2013	25
2014	41
2015	46
2016	47
2017	56
2018	46
2019	64
2020	64
2021	68
2022	81
2023	78
2024	85
2025	87

1

Infections following bispecific antibodies in myeloma: a systematic review and meta-analysis.

Reynolds G, Cliff ERS, Mohyuddin GR, Popat R, Midha S, Liet Hing MN, Harrison SJ, Kesselheim AS, Teh BW. Reynolds G, et al. Among authors: kesselheim as. Blood Adv. 2023 Oct 10;7(19):5898-5903. doi: 10.1182/bloodadvances.2023010539. Blood Adv. 2023. PMID: 37467036 Free PMC article.

2

Comparative effectiveness and safety of single inhaler triple therapies for chronic obstructive pulmonary disease: new user cohort study.

Feldman WB, Suissa S, Kesselheim AS, Avorn J, Russo M, Schneeweiss S, Wang SV. Feldman WB, et al. Among authors: kesselheim as. BMJ. 2024 Dec 30;387:e080409. doi: 10.1136/bmj-2024-080409. BMJ. 2024. PMID: 39797646 Free PMC article.

3

FDA Approval and Regulation of Pharmaceuticals, 1983-2018.

Darrow JJ, Avorn J, Kesselheim AS. Darrow JJ, et al. Among authors: kesselheim as. JAMA. 2020 Jan 14;323(2):164-176. doi: 10.1001/jama.2019.20288. JAMA. 2020. PMID: 31935033

4

Antibody Patent Evolution.

Teng TW, Kesselheim AS, Tu SS. Teng TW, et al. Among authors: kesselheim as. IEEE Pulse. 2022 Sep-Oct;13(5):33-37. doi: 10.1109/MPULS.2022.3209128. IEEE Pulse. 2022. PMID: 36301809

5

Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval.

Liu ITT, Kesselheim AS, Cliff ERS. Liu ITT, et al. Among authors: kesselheim as. JAMA. 2024 May 7;331(17):1471-1479. doi: 10.1001/jama.2024.2396. JAMA. 2024. PMID: 38583175 Free PMC article.

6

Chronic Obstructive Pulmonary Disease Exacerbations and Pneumonia Hospitalizations Among New Users of Combination Maintenance Inhalers.

Feldman WB, Avorn J, Kesselheim AS, Gagne JJ. Feldman WB, et al. Among authors: kesselheim as. JAMA Intern Med. 2023 Jul 1;183(7):685-695. doi: 10.1001/jamainternmed.2023.1245. JAMA Intern Med. 2023. PMID: 37213116 Free PMC article.

7

Promoting confidence in cost-effectiveness analyses.

Raymakers AJN, Kesselheim AS. Raymakers AJN, et al. Among authors: kesselheim as. BMJ. 2022 Jun 22;377:o1452. doi: 10.1136/bmj.o1452. BMJ. 2022. PMID: 35732298 No abstract available.

8

Medicare Negotiation's Drug Reformulation Problem.

Vogel M, Rome BN, Kesselheim AS, Feldman WB. Vogel M, et al. Among authors: kesselheim as. Ann Intern Med. 2024 Jun;177(6):817-819. doi: 10.7326/M24-0138. Epub 2024 Apr 30. Ann Intern Med. 2024. PMID: 38684103 No abstract available.

9

340B-Where Do We Go From Here?

Kishore S, Nayak RK, Kesselheim AS. Kishore S, et al. Among authors: kesselheim as. JAMA. 2023 Aug 15;330(7):593-594. doi: 10.1001/jama.2023.11056. JAMA. 2023. PMID: 37505512

10

Active postmarketing device surveillance as a legislative priority.

Feldman WB, Kesselheim AS. Feldman WB, et al. Among authors: kesselheim as. BMJ. 2025 Mar 12;388:r484. doi: 10.1136/bmj.r484. BMJ. 2025. PMID: 40081836 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

841 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

841 results

Results by year